GLP-1s and Menopause: What Women Over 40 Should Know

Updated August 2026

Somewhere in your forties, the rules of your own body seem to change. You eat the way you always have. You move the way you always have. The scale climbs anyway, and it settles in a new place, around your middle.

This is not about willpower. It is a shift in your metabolism, driven by falling estrogen. And it is happening right as a new class of weight-loss drugs, the GLP-1 medications, has become one of the most talked-about tools in midlife health.

So the real question is not whether these drugs work. It is what they actually address, and what they leave untouched.

Key takeaways

• Midlife weight gain is largely mechanical: falling estrogen shifts fat storage toward the belly and lowers insulin sensitivity, so the same habits produce a different result.
• GLP-1 medications reliably reduce weight and visceral fat, and early data suggests they may work even better alongside hormone therapy.
• For women over 40, three things need attention: muscle loss, bone density, and how the drug's slowed digestion can affect oral estrogen.
• A GLP-1 addresses weight. It does not address the nervous-system symptoms, such as brain fog, tension, and night wakings, that many women rank as most disruptive. Those run on a different pathway.

Why weight changes in perimenopause

Weight gain at midlife is mostly a story about estrogen and where your body decides to store fat. When estrogen falls, fat moves from your hips and thighs toward your abdomen.

Estrogen helps regulate how your body stores fat and how well your cells respond to insulin. As levels drop, several things happen at once.

• Fat storage moves inward. More fat settles as visceral fat, the deeper kind packed around your organs. This is the fat linked to inflammation and heart risk.
• Insulin sensitivity dips. Your cells respond less well to insulin, so your body stores fuel more easily than it burns it.
• Muscle quietly declines. You lose lean muscle with age, and muscle is what keeps your resting metabolism high.

A large study following women through the transition found the pace of fat gain roughly doubled once it began, while lean mass slipped at the same time. The scale often looked steady, because muscle loss hid the fat gain. Source: Body composition changes during the menopause transition, SWAN (Greendale et al., 2019).

Your body is not failing. Its fuel-handling rules have been rewritten, and the old approach no longer gives the old result.

What GLP-1 medications do, and the evidence in menopausal women

GLP-1 medications copy a gut hormone that tells your brain you are full and slows how fast your stomach empties. The result is less hunger, smaller portions, and steady weight loss, often 10 to 20% of body weight.

They also reduce visceral fat, the exact fat that estrogen loss encourages. That is one reason they have drawn so much interest for women in midlife. Roughly one in five women aged 50 to 64 report having used a GLP-1, the highest rate of any group. Source: GLP-1 Agonists in Perimenopause, RAND (Rancaño and Donofry, 2025).

There is early evidence the effect may be stronger with hormone therapy. In one study of postmenopausal women on semaglutide, those also using hormone therapy lost about 16% of their body weight at one year, compared with about 12% for those not on hormone therapy. Source: Weight loss response to semaglutide with and without hormone therapy, Menopause (2024). The group was small, so this is a promising signal rather than a settled fact.

What women over 40 should watch: muscle, bone, and absorption

The concern for women over 40 is not whether GLP-1s cause weight loss. It is the kind of weight lost, and how the drug interacts with a body already losing estrogen.

Muscle and bone

When you lose weight quickly, some of it comes from muscle and bone, not just fat. Estimates suggest 25 to 40% of weight lost on a GLP-1 can come from lean mass, which includes muscle. Source: GLP-1 medications and muscle loss, Mayo Clinic.

For midlife women, that lands on top of losses already underway. Menopause speeds bone loss on its own, and weight loss can add to it. One bone expert calls the overlap of menopause, medication, and rapid weight loss a possible "perfect storm" for bone density. Source: Menopause, GLP-1 drugs and bone loss, UCHealth.

Two habits do most of the protecting:

• Protein. Aim for more than the old baseline. Many experts suggest 1.2 to 1.6 grams per kilogram of body weight per day while losing weight, to give your muscles what they need to hold on. Source: Mayo Clinic.
• Strength training. Resistance work, two or three times a week, protects muscle and bone better than cardio alone. Women who add strength training keep more lean mass than those who do not.

If you want a starting point, our guide to strength training in perimenopause walks through the basics.

Oral estrogen and slowed digestion

GLP-1s slow how fast your stomach empties. That is part of how they curb appetite, but it can also affect how well your gut absorbs oral estradiol, the pill form of estrogen used in some hormone therapy.

Because of this, some clinicians suggest transdermal estrogen, meaning patches, gels, or sprays, which enter through the skin and skip the gut entirely. Source: The GLP-1 update, Dr. Mary Claire Haver (2026). This is a conversation for you and your prescribing doctor, not a change to make on your own.

You may also have seen the "microdosing" trend, where women use lower-than-standard doses to ease side effects. It is popular, but it is still off-label and best done under medical guidance.

What GLP-1s do and do not address

A GLP-1 is a metabolic tool. It works on hunger, blood sugar, and fat. It was never built to touch the nervous-system symptoms that many women find most disruptive in perimenopause.

This distinction matters, because weight is often not the symptom women rank as worst. In Project M's consumer research study of 35 women, the highest-severity symptoms were brain fog, tension, emotional swings, and night wakings, not weight. Source: Project M perimenopause study results.

Different tools, different pathways. A GLP-1 can move the number on the scale and still leave the 2 a.m. wakings exactly where they were. If those symptoms are your real burden, they need a separate approach. Our guides to perimenopause brain fog, cortisol and perimenopause, and menopause sleep disruption go deeper on each.

Where The Shift fits

The Shift is Project M's daily herbal protocol for perimenopause, built on a 600-year-old Traditional Chinese Medicine (TCM) formula and modernized for the stressed Western woman. Learn more about The Shift.

It is not a weight-loss drug, and it does not compete with one. It works on a different layer: the stress response that drives the tension, the foggy thinking, and the restless nights. Where a GLP-1 targets metabolism, The Shift is formulated to support the nervous system as it recalibrates through the transition.

For a woman on a GLP-1 who still cannot switch off at night, these are two different tools for two different problems. Many women use botanical support alongside hormone therapy for the same reason, because one tool rarely covers everything.

Frequently asked questions

Can I take a GLP-1 and hormone therapy together? Many women do, and early research suggests the combination may lead to greater weight loss than the medication alone. Because GLP-1s slow digestion, your doctor may suggest a patch or gel instead of oral estrogen. This is a decision to make with your prescriber.

Will a GLP-1 help my brain fog or sleep? Not directly. These drugs act on appetite and blood sugar, not on the stress-response and hormone shifts behind brain fog, tension, and night wakings. Those symptoms usually need their own approach.

How do I protect my muscle and bone on a GLP-1? Eat more protein than you used to, often around 1.2 to 1.6 grams per kilogram of body weight daily, and do resistance training two or three times a week. Ask your doctor about a baseline bone-density scan before you start.

Is microdosing a GLP-1 safe? Lower doses may reduce side effects, but microdosing is off-label and under-studied. Do it only with medical supervision, never on your own.

Does The Shift help with weight? The Shift is designed to support the nervous system and stress response, not to drive weight loss. It fits women whose hardest symptoms are foggy thinking, tension, mood swings, and disrupted sleep.

A note on medical care

GLP-1 medications are prescription drugs. Whether to start one, at what dose, and how it fits with hormone therapy are decisions that belong with your doctor, based on your full health history. This article is for understanding, not medical advice.

Read next

• Menopause fatigue: why you are so tired and what actually helps
• Cortisol and perimenopause: the stress connection
• Strength training in perimenopause: where to start
• Perimenopause brain fog: what it is and why it happens
• Menopause sleep disruption: why you wake at 2 a.m.